Rubius Therapeutics, Inc RUBY

Pmozzillo Premium

RUBY - LONG

LeLaf Premium

Bullish Pennant (114%) Pros: Volume during post formation Descending volume during triangle formation Golden cross in blue PPS above 50MA and 200MA RS above 0 and ascending ATR Ascending R/R ratio above 6 250RSI above 50 and ascending Cons: 200MA Flat Target: PT = 52.31$ Help how ever you can to keep this alive. Thank you to those who have donated Coins! Always...

AlenCiken

Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors, Demonstrating Single-Agent Activity. RTX-240 Generated Partial Responses in Metastatic Anal Cancer and Metastatic Uveal Melanoma Patients; No DLTs or Related Grade 3/4 Adverse Events RTX-240 Promoted Trafficking of NK and T Cells...

Several

Yeah, there was terrific news on this stock about a cancer drug they made but the sell pressure is going to be SO high. Make sure to buy the dip too! Very great long term stock.

WBG20

First bullish break on descending wedge (yellow) since IPO which was followed by a higher low. SAR and MA's indicating momentum has returned to the bulls. Double bottom on the Stoch, good indicator of a new move upward. A higher run similar to the last one would result in some great short term profit.

MaxPaul

NASDAQ:RUBY Setting a nice bullish consolidation. Any break of resistance is a trigger long for me. Earnings out so soon throws a spanner in the works though so would ideally like to wait and see how it reacts to it's earnings Short float= 12.7% Keep risk tight (area marked on chart) Be aware this is a pharma stock so they have been known to be wild (news...